Home   Business   Article

OBRIZUM and Arcus Answer shortlisted for AI innovation award


By Paul Brackley


The products of two Cambridge companies have been shortlisted in a UK top 10 of artificial intelligence innovations.

CamBioScience's CEO Dr Chibeza Agley, left, chief marketing officer, Dr Sarra Achouri and chief operating officer Dr Jürgen Fink. Picture: Keith Heppell
CamBioScience's CEO Dr Chibeza Agley, left, chief marketing officer, Dr Sarra Achouri and chief operating officer Dr Jürgen Fink. Picture: Keith Heppell

OBRIZUM, the AI-learning platform from CamBioScience, and Arcus Answer, the 24/7 customer call answering service from Arcus Global, are among those in the Digital Leaders 100 list, which is now open for public voting. Both are in the new AI Innovation category.

Digital Leaders is a nationwide programme promoting digital transformation across government, industry and charities. Its DL100 list features people and organisations leading the way across multiple sectors, and this year more than 500 were considered for inclusion.

CamBioScience, based at Barclays Eagle Labs on Chesterton Road, has created OBRIZUM to put the power of AI into e-learning programmes. This helps organisations to create automatically non-linear curricula, personalise the learning of staff and offers detailed analytics.

CEO Dr Chibeza Agley said: “We are extremely proud to be recognized in the DL100 AI Innovation category. We want to revolutionise the way people produce, consume, and monitor fully personalised e-learning.

“OBRIZUM is powered by our proprietary AI technology to automate, adapt and analyse your e-learning experience. Our mission is to empower people to learn deeper and faster today, so they can build a better tomorrow.”

Arcus Global, based at the Allia Future Business Centre in King’s Hedges Road, designed Arcus Answer to handle customer calls, improve service, save staff time and organisations money. The average call to a UK contact centre costs an organisation £3.69. With Arcus Answer, that is reduced to less than £1.

It uses Amazon AI technology and has been compared to talking to Amazon's Alexa.

Arcus Global is a previous winner of the Cambridge Judge Business School High Growth Award at the SME Cambridgeshire Business Awards
Arcus Global is a previous winner of the Cambridge Judge Business School High Growth Award at the SME Cambridgeshire Business Awards

The technology has been used by the NHS Business Services Authority (NHSBSA) for its around-the-clock European Health Insurance Card line since September 2018. The NHBSA has found 40 per cent of calls can be resolved by AI.

The efficiency of other calls are also sped up by asking callers to key in a reference number that pops up on call answerer’s screens, saving an average of 90 seconds a call - and £500,000 a year.

Arcus Global has since created other services for the NHS and central government.

Local authorities could link it to back-end systems to deal with transactions such as booking appointments or ordering parking permits.

Robin Knowles, CEO of Digital Leaders, said: "Our seventh Digital Leaders 100 reflects much of the fantastic work going on across the UK’s sectors. It’s a celebration of those leading change, but who are not perhaps household names yet.”

Others in the AI Innovation category include Hermes Chatbot, a self-service tracking service from the parcel company, and IMGeospatial’s AIMEE, which uses AI, location data and remote sensing to provide business intelligence for organisations including Anglian Water.

You can vote for a winner in this and other categories at http://digileaders100.com/ until May 10. The final list order and category winners will be announced at an event on June 20.

Read more

CamBioScience secures £1.1m investment to scale-up AI-enhanced e-learning platform OBRIZUM

Arcus Global is test venue for Allia's office energy use pilot



COMMENTS
()


Iliffe Media does not moderate comments. Please click here for our house rules.

People who post abusive comments about other users or those featured in articles will be banned.

Thank you. Your comment has been received and will appear on the site shortly.

 

Terms of Comments

We do not actively moderate, monitor or edit contributions to the reader comments but we may intervene and take such action as we think necessary, please click here for our house rules.

If you have any concerns over the contents on our site, please either register those concerns using the report abuse button, contact us here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More